EUVIMEDEUVIMED entdecken
Open Access

Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID

Helen Burton-Murray iD, Aluma Chovel Sella, Julia E Gydus, Micaela Atkins, Lilian P Palmer, Megan C Kuhnle, Kendra R Becker iD, Lauren E Breithaupt iD, Kathryn S Brigham, Anna Aulinas iD, Kyle Staller, Kamryn T Eddy iD und 4 weitere

International Journal of Eating Disorders · 2024-11 · 57 (11) · 2167-2175

DOI: 10.1002/eat.24243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Eating Disorders, online erschienen am 28.06.2024. Verfasst von Helen Burton-Murray und 15 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Comorbidity, Biomarkers, Cardiovascular Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIMH NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Avoidant/restrictive food intake disorder (ARFID) is common among populations with nutrition‐related medical conditions. Less is known about the medical comorbidity/complication frequencies in youth with ARFID. We evaluated the medical comorbidities and metabolic/nutritional markers among female and male youth with full/subthreshold ARFID across the weight spectrum compared with healthy controls (HC).

Method

In youth with full/subthreshold ARFID ( n = 100; 49% female) and HC ( n = 58; 78% female), we assessed self‐reported medical comorbidities via clinician interview and explored abnormalities in metabolic (lipid panel and high‐sensitive C‐reactive protein [hs‐CRP]) and nutritional (25[OH] vitamin D, vitamin B12, and folate) markers.

Results

Youth with ARFID, compared with HC, were over 10 times as likely to have self‐reported gastrointestinal conditions (37% vs. 3%; OR = 21.2; 95% CI = 6.2–112.1) and over two times as likely to have self‐reported immune‐mediated conditions (42% vs. 24%; OR = 2.3; 95% CI = 1.1–4.9). ARFID, compared with HC, had a four to five times higher frequency of elevated triglycerides (28% vs. 12%; OR = 4.0; 95% CI = 1.7–10.5) and hs‐CRP (17% vs. 4%; OR = 5.0; 95% CI = 1.4–27.0) levels.

Discussion

Self‐reported gastrointestinal and certain immune comorbidities were common in ARFID, suggestive of possible bidirectional risk/maintenance factors. Elevated cardiovascular risk markers in ARFID may be a consequence of limited dietary variety marked by high carbohydrate and sugar intake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ComorbidityBiomarkersCardiovascular DiseasesHumansMaleFemaleAdolescentAvoidant Restrictive Food Intake DisorderC-Reactive ProteinChildHeart Disease Risk Factors

Stichwörter der Autor:innen

allergy and immunologyavoidant/restrictive food intake disorderfeeding and eating disordersfood allergiesgastrointestinal diseasehigh‐sensitive C‐reactive proteinlipid panelmetabolic diseasesnutritional insufficiencytriglycerides

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • Center for Neurointestinal Health, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mass General Brigham Eating Disorders Research Collaborative, Boston, Massachusetts, USA.
  • The Jesse Z. and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Neuroendocrine Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Helen Burton-Murray, Kendra R Becker, Lauren E Breithaupt, Anna Aulinas, Kamryn T Eddy, Madhusmita Misra, Jennifer J Thomas

Förderung

  • NIDDK NIH HHS
  • NIMH NIH HHS
  • NCATS NIH HHS
  • National Institute of Mental Health
  • National Center for Advancing Translational Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Nutrition Obesity Research Center at Harvard

Zitieren

APA

Burton-Murray, H., Sella, A. C., Gydus, J. E., Atkins, M., Palmer, L. P., Kuhnle, M. C., Becker, K. R., Breithaupt, L. E., Brigham, K. S., Aulinas, A., Staller, K., Eddy, K. T., Misra, M., Micali, N., Thomas, J. J., & Lawson, E. A. (2024). Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID. International Journal of Eating Disorders, 57(11), 2167-2175. https://doi.org/10.1002/eat.24243

Vancouver

Burton-Murray H, Sella AC, Gydus JE, Atkins M, Palmer LP, Kuhnle MC, et al. Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID. International Journal of Eating Disorders. 2024;57(11):2167-2175. doi:10.1002/eat.24243

BibTeX
@article{BurtonMurray2024,
  author = {Burton-Murray, Helen and Sella, Aluma Chovel and Gydus, Julia E and Atkins, Micaela and Palmer, Lilian P and Kuhnle, Megan C and Becker, Kendra R and Breithaupt, Lauren E and Brigham, Kathryn S and Aulinas, Anna and Staller, Kyle and Eddy, Kamryn T and Misra, Madhusmita and Micali, Nadia and Thomas, Jennifer J and Lawson, Elizabeth A},
  title = {Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID},
  journal = {International Journal of Eating Disorders},
  year = {2024},
  volume = {57},
  number = {11},
  pages = {2167--2175},
  doi = {10.1002/eat.24243}
}
Kostenlos starten →